These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9678092)

  • 21. Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles.
    Pakarinen PI; Suvisaari J; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1997 Jul; 68(1):59-64. PubMed ID: 9207585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The morphologic response of the human endometrium to long-term treatment with progestational agents.
    Ludwig H
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):796-808. PubMed ID: 7065058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 20 micrograms ethinylestradiol/150 micrograms desogestrel, with respect to efficacy, cycle control and tolerance.
    Endrikat J; Jaques MA; Mayerhofer M; Pelissier C; Müller U; Düsterberg B
    Contraception; 1995 Oct; 52(4):229-35. PubMed ID: 8605781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ovarian activity during regular oral contraceptive use.
    Crosignani PG; Testa G; Vegetti W; Parazzini F
    Contraception; 1996 Nov; 54(5):271-3. PubMed ID: 8934059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of long-term gestodene-containing oral contraceptive administration on hemostasis.
    Abbate R; Pinto S; Rostagno C; Bruni V; Rosati D; Mariani G
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):424-9. PubMed ID: 2372036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endometrial morphology during a normophasic and a triphasic regimen: a comparison.
    Wynants P; Ide P
    Contraception; 1986 Feb; 33(2):149-57. PubMed ID: 2938885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Desogestrel, norgestimate, and gestodene: the newer progestins.
    Kaplan B
    Ann Pharmacother; 1995; 29(7-8):736-42. PubMed ID: 8520092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of transvaginal ultrasonography and endometrial biopsy in endometrial surveillance in postmenopausal HRT users.
    Hänggi W; Bersinger N; Altermatt HJ; Birkhäuser MH
    Maturitas; 1997 Jun; 27(2):133-43. PubMed ID: 9255748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and metabolic effects of a triphasic pill containing gestodene.
    Fruzzetti F; Ricci C; Nicoletti I; Fioretti P
    Contraception; 1992 Oct; 46(4):335-47. PubMed ID: 1486772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New progestins--clinical experiences: gestodene.
    Shoupe D
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1562-8. PubMed ID: 8178907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of cycle control and effect on well-being of monophasic gestodene-, triphasic gestodene- and monophasic desogestrel-containing oral contraceptives. Gestodene Study Group.
    Bruni V; Croxatto H; De La Cruz J; Dhont M; Durlot F; Fernandes MT; Andrade RP; Weisberg E; Rhoa M
    Gynecol Endocrinol; 2000 Apr; 14(2):90-8. PubMed ID: 10836195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of a combined oral contraceptive containing 3 mg of drospirenone and 30 microg of ethinyl estradiol on the human endometrium.
    Lüdicke F; Johannisson E; Helmerhorst FM; Campana A; Foidart J; Heithecker R
    Fertil Steril; 2001 Jul; 76(1):102-7. PubMed ID: 11438327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
    N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double blind randomized control trial, comparing effect of drospirenone and gestodene to sexual desire and libido.
    Oranratanaphan S; Taneepanichskul S
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S17-22. PubMed ID: 17726807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Six-month carbohydrate metabolism studies in women using oral contraceptives containing gestodene and ethinyl estradiol.
    Spellacy WN; Tsibris JC; Hunter-Bonner DL; Smalling S; Chez RA; Angel JL; O'Brien WF
    Contraception; 1992 Jun; 45(6):533-9. PubMed ID: 1617962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progestogen potency in oral contraceptive pills.
    Gillmer MD
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1048-52. PubMed ID: 3118717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of gestodene and ethinylestradiol in 14 women during three months of treatment with a new tri-step combination oral contraceptive: serum protein binding of gestodene and influence of treatment on free and total testosterone levels in the serum.
    Kuhnz W; Baumann A; Staks T; Dibbelt L; Knuppen R; Jütting G
    Contraception; 1993 Oct; 48(4):303-22. PubMed ID: 8222659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of ovulation by a new low-dose monophasic contraceptive containing gestodene.
    Thomas KH; Vankrieken L
    Int J Fertil; 1989 Sep; 34 Suppl():10-21. PubMed ID: 2576249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.
    Elomaa K; Rolland R; Brosens I; Moorrees M; Deprest J; Tuominen J; Lähteenmäki P
    Am J Obstet Gynecol; 1998 Jul; 179(1):41-6. PubMed ID: 9704763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The oestrogenic effects of gestodene, a potent contraceptive progestin, are mediated by its A-ring reduced metabolites.
    Lemus AE; Zaga V; Santillán R; García GA; Grillasca I; Damián-Matsumura P; Jackson KJ; Cooney AJ; Larrea F; Pérez-Palacios G
    J Endocrinol; 2000 Jun; 165(3):693-702. PubMed ID: 10828854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.